Suita, Japan

Keiichi Shintomi

This inventor holds 2 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1981-1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keiichi Shintomi. Retrieved from https://idiyas.com/inventor/keiichi-shintomi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1981-1983

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Keiichi Shintomi: Innovator in Pharmaceutical Chemistry

Introduction

Keiichi Shintomi is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues. With a total of 2 patents to his name, Shintomi's work is recognized for its potential therapeutic applications.

Latest Patents

Shintomi's latest patents include innovative piperazine derivatives that are useful in decreasing intracranial pressure. One of his notable inventions is a piperazine derivative characterized by a specific formula, which includes various substituents that enhance its pharmacological properties. This compound has demonstrated an ability to lower intracranial pressure and has a depressant effect on the central nervous system. Additionally, he has developed methods for reducing increased intracranial pressure in warm-blooded animals through the administration of a propanol derivative.

Career Highlights

Keiichi Shintomi is currently associated with Tanabe Seiyaku Company, Limited, where he continues to advance his research in pharmaceutical innovations. His work has contributed to the understanding and treatment of conditions related to increased intracranial pressure, showcasing his commitment to improving health outcomes.

Collaborations

Shintomi has collaborated with esteemed colleagues such as Mitsunori Gaino and Takeshi Kanno. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Keiichi Shintomi's contributions to pharmaceutical chemistry highlight his innovative spirit and dedication to addressing significant health challenges. His work continues to pave the way for advancements in medical treatments, making a lasting impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…